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Summary The finding that PDGF production is common in normal as well as transformed cells indicate that
PDGF has a function in autocrine and paracrine stimulation of cells in several physiological and pathological
conditions. The expression of mRNA for the two chains of PDGF are independently regulated. The fact that
the different dimeric forms of PDGF have different functional effects, indicate that the cellular response to
PDGF may be more complex than previously thought, and may involve binding to more than one receptor.
The cellular effects ascribed to PDGF, growth stimulation, ruffling and chemotaxis, seems to be mainly
associated with B chain containing dimers. The function of PDGF-AA remains to be elucidated.
Platelet-derived growth factor (PDGF) is a major mitogen
for connective tissue cells and glial cells cultured in vitro (for
reviews see Heldin et al., 1985; Ross et al., 1986). Its in vivo
function has not been elucidated, but is localization to the
blood platelets in combination with the facts that PDGF
stimulates not only proliferation, but also matrix production
and chemotaxis of connective tissue cells, has led to the
assumption that PDGF has a role in wound healing.
However, recent findings that PDGF does not only occur in
platelets, but is produced by a variety of different normal
and transformed cell types, indicate that PDGF may have
wider functions, mediating cell proliferation in a number of
normal and pathological conditions.
PDGF exerts its mitogenic effect via binding to a specific
170-185 kD cell surface receptor (reviewed in Heldin &
Ronnstrand, 1988). The receptor is a transmembrane protein
with an external ligand binding domain, and an internal
domain with a protein tyrosine kinase activity that becomes
activated after ligand binding (Ek et al., 1982; Yarden et al.,
1986).
The mechanism whereby the mitogenic signal is
transmitted from the activated receptor and further into the
cell, is largely unknown. The fact that several growth factor
receptors and oncogene products are protein tyrosine kinases
(Hunter, 1987), indicates that tyrosine phosphorylation of
specific substrates is important in stimulation of cell growth.
In spite of extensive investigations (Cooper et al., 1982; Ek
& Heldin, 1984; Frackelton et al., 1984), no substrate for the
PDGF receptor kinase, with a proven role in the mitogenic
pathway has yet been found. Other signals that have been
discussed as part of the PDGF-stimulated mitogenic
pathway, include turnover of phosphatidyl-inositol, with
subsequent elevation of the cytoplasmic Ca2+ concentration
(Moolenaar et al., 1984), and stimulation of protein kinase C
(Rozengurt et al., 1983), as well as induction of specific
genes (Cochran et al., 1983, Kelly et al., 1983; Kruijer et al.,
1984; Muller et al., 1984, Greenberg & Ziff, 1984).
This review will focus on structural and functional aspects
of PDGF-like factors, as well as their possible involvement
in autocrine or paracrine stimulation ofcell growth.
Structures ofPDGF
PDGF is a 30kD dimeric molecule, composed of two
disulphide-bonded polypeptide chains denoted A and B
(Johnsson et al., 1984). The PDGF B chain is almost
identical to p28si q the transforming protein of simian
sarcoma virus (SSV) (Waterfield et al., 1983; Doolittle et al.,
1983; see further below). Analyses of cDNAs of the A
(Betsholtz et al., 1986b) and the B (Josephs et al., 1984;
Collins et al., 1985: Rao et al., 1986) chain of PDGF
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Figure 1 Schematic illustration of the different dimeric forms of
PDGF. Both the A and B chains are synthesized as precursor
molecules (upper part of the figure) which undergo proteolytic
processing (arrows). Amino acid sequence identities are marked
by black colour. The two polypeptide chains are assembled into
homodimers (PDGF-AA or PDGF-BB) or heterodimers (PDGF-
AB) (lower part of the figure). The dimers are held together by
disulphide bonds. Note, that it is not known exactly which
cysteine residues that are involved in inter-chain disulphide
bonds.
revealed that both are synthesized as precursor molecules
with hydrophobic signal sequences indicating that they are
secretory products. The two chains, which are proteolytically
processed after dimerization, are homologous to each other;
within the mature parts the amino acid sequence similarity is
60% (Figure 1) (Johnsson et al., 1984; Betsholtz et al.,
1986b).
Evidence was recently obtained that a major part of
PDGF purified from human platelets is PDGF-AB, i.e. a
heterodimer of one A chain and one B chain (Hammacher et
al., 1988a). PDGF purified from porcine platelets (Stroobant
& Waterfield, 1984), as well as the transforming protein of
SSV (Robbins et al., 1983) have been identified as PDGF-
BB. Finally, structural analyses of PDGF-like factors puri-
fied from the conditioned media of human osteosarcoma
(Heldin et al., 1986b) melanoma (Westermark et al., 1986b)
and glioma (Hammacher et al., 1986b) cell lines, revealed the
existence also of PDGF-AA. Thus, all possible dimeric
combinations of PDGF chains have been found (Figure 1).
SSV-transformation is exerted by externalized PDGF-BB
The structural homology between p28Ss' and PDGF
(Waterfield et al., 1983; Doolittle et al., 1983; Robbins et al.,
1983), led to the hypothesis that a PDGF-like growth factor
is involved in SSV-transformation. This hypothesis has
received support from several subsequent observations. First,
SSV-transformed cells in vitro produce PDGF-like growth
factors which bind to and activate the PDGF receptor
(Deuel et al., 1983; Bowen-Pope et al., 1984; Owen et al.,
1984; Garrett et al., 1984; Huang et al., 1984; Johnsson et
al., 1985). Second, only cell types that respond to PDGF, i.e.
have PDGF receptors, can be transformed by SSV
(Deinhardt, 1980; Leal et al., 1985). Finally, SSV-trans-
formation can be reverted by agents that prevent the binding
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of PDGF to its receptor, e.g. PDGF antibodies (Johnsson et
al., 1985) and suramin (Betsholtz et al., 1986a). The morpho-
logical and functional characteristics of acutely SSV-
transformed human fibroblasts indicate that the infected cell
receives a powerful autocrine stimulation to grow, but
other features that have been associated with the malignant
phenotype, e.g. immortalization, do not occur (Johnsson et
al., 1986). In conclusion, studies on SSV-transformed cells in
vitro are fully compatible with a simplistic model for SSV-
transformation, involving the autocrine action of a factor
similar to PDGF-BB. However, to explain the malignant
glioblastomas and fibrosarcomas that develop in marmoset
monkeys infected by SSV (Deinhardt, 1980), one has to
propose that additional genetic alterations, which are
responsible for the development of the fully malignant
phenotype, occur in the infected cells (Westermark et al.,
1986a).
Production ofPDGF in human tumour cells
Expression of PDGF A or B chain mRNA, or production
of PDGF receptor competing activity, have been found in a
variety of human tumour cell lines (reviewed in Heldin et al.,
1986a). No correlation has been found between the
expressions of the A and B chains, indicating that they are
independently regulated.
Several cell lines of connective tissue cell origin or glial
origin have been found to produce PDGF. Since the normal
counterparts of these cells respond to PDGF, it is possible
that the endogenous growth factor production has an
autocrine effect and drives tumour cell growth. PDGF
production is common in human glioma cell lines; 23 and 17
cell lines, out of 23 investigated, express A and B chain
mRNA, respectively (Nister et al., 1988b).
Cell lines derived from cell types that do not respond to
PDGF have also been found to produce PDGF. Since these
tumour cells lack PDGF receptors it is highly unlikely that
the endogenous PDGF production has any impact on
tumour cell growth. PDGF production is common also in
these tumour types; 8 and 9 mammary carcinoma cell lines,
out of 10 investigated, were found to express the A and B
chain mRNA, respectively (Perez et al., 1987). If PDGF
production also occurs in carcinomas in vivo, it is possible
that this contributes to the stimulation of stroma cell
proliferation, which is a common finding in many
carcinomas.
PDGF in autocrine andparacrine stimulation ofnormal cells
Smooth muscle cells (Seifert et al., 1984; Nilsson et al., 1985)
and placental cytotrophoblasts (Goustin et al., 1985) have
been found to produce PDGF. Since these cell types also
respond to PDGF, it is possible that the PDGF production
serves an autocrine function. This suggests a role of PDGF
in pathophysiological reactions in the vessel wall and in
placental growth. Clearly such autocrine systems in normal
cells must be subjected to regulation, but little is known
about the factors that exert such control functions. It was
recently found that stimulation of human fibroblasts by
mitogens led to expression of PDGF A chain mRNA and
production of PDGF receptor competing activity (Paulsson
et al., 1987). Though the interpretation of this finding is not
clear, it suggests the presence of a positive feed-back mecha-
nism which may amplify the mitogenic signal.
Endothelial cells (DiCorleto & Bowen-Pope, 1983) and
activated macrophages (Shimokado et al., 1985; Martinet et
al., 1986) are examples of normal cells that produce PDGF
but do not have PDGF receptors. Though it is unlikely that
the PDGF production in these cases has any autocrine
function, it is possible that the factor stimulates
neighbouring cells in a paracrine fashion. Thus, PDGF
secreted by regenerating endothelial cells in the vessel wall
could stimulate the proliferation of underlying smooth
muscle cells, and PDGF secreted by activated macrophages
could be involved in the stimulation of connective tissue cells
that is often seen in chronic inflammatory processes.
Difference in thefunctional activities ofdifferent dimeric
forms ofPDGF
PDGF-like growth factors were recently purified from the
conditioned medium of a human glioma cell line, U-343
MGa Cl 2:6 (Hammacher et al., 1986b), which expresses
both PDGF A and B chain mRNA (Betsholtz et al., 1986b).
All three possible dimeric forms of PDGF were identified,
but PDGF-AA was by far the predominant species. Analyses
of PDGF-AA in several functional assays revealed
differences compared to PDGF-AB; PDGF-AA had lower
mitogenic activity, lower ability to stimulate actin
reorganization and membrane ruffling, and no chemotactic
activity (Nister et al., 1988a). Receptor binding experiments
suggested that there exists more than one PDGF receptor
class. The observed dissimilarities in functional activities of
different dimeric forms of PDGF, might be explained by
differences in ligand binding specificity between these recep-
tor classes.
We thank Linda Baltell for valuable help in the preparation of this
manuscript.
References
BETSHOLTZ, C., JOHNSSON, A., HELDIN, C.-H. & WESTERMARK, B.
(1986a). Efficient reversion of SSV-transformation and inhibition
of growth factor-induced mitogenesis by suramin. Proc. Natl
Acad. Sci. USA, 83, 6440.
BETSHOLTZ, C., JOHNSSON, A., HELDIN, C.-H. & 9 others (1986b).
cDNA sequence and chromosomal localization of human
platelet-derived growth factor A-chain and its expression in
tumour cell lines. Nature, 320, 695.
BOWEN-POPE, D.F., VOGEL, A. & ROSS, R. (1984). Production of
platelet-derived growth factor-like molecules and reduced
expression of platelet-derived growth factor receptors accompany
transformation by a wide spectrum of agents. Proc. Natl Acad.
Sci. USA, 81, 2396.
COCHRAN, B.H., REFFEL, A.C. & STILES, C.D. (1983). Molecular
cloning of gene sequences by regulated platelet-derived growth
factor. Cell, 33, 939.
COLLINS, T., GINSBURG, D., BOSS, J.M., ORKIN, S.H. & POBER, J.S.
(1985). Cultured human endothelial cells express platelet-derived
growth factor B chain: cDNA cloning and structural analysis.
Nature, 316, 748.
COOPER, J.A., BOWEN-POPE, D.F., RAINES, E., ROSS, R. & HUNTER,
T. (1982). Similar effects of platelet-derived growth factor and
epidermal growth factor on the phosphorylation of tyrosine in
cellular proteins. Cell, 31, 263.
DiCORLETO, P.E. & BOWEN-POPE, D.F. (1983). Cultured endothelial
cells produce a platelet-derived growth factor-like protein. Proc.
Natl Acad. Sci. USA, 80, 1919.
DEINHART, F. (1980). The biology of primate retrovirus. In: Klein
G. (ed). Viral Oncology. p. 359. New York: Raven Press.
DEUEL, T.F., HUANG, J.S., HUANG, S.S. STROOBANT, P. &
WATERFIELD, M.D. (1983). Expression of a platelet-derived
growth factor-like protein in simian sarcoma virus transformed
cells. Science, 221, 1348.
DOOLITTLE, T.F., HUNKAPILLER, M.W., HOOD, L.E. & 4 others
(1983), Simian sarcoma virus oncogene, v-sis, is derived from
the gene (or genes) encoding a platelet-derived growth factor.
Science, 221, 275.PLATELET DERIVED GROWTH FACTOR 593
EK, B. & HELDIN, C.-H. (1984). Use of an antiserum against
phosphotyrosine for the identification of phosphorylated
components in human fibroblasts stimulated by platelet-derived
growth factor. J. Biol. Chem., 259, 11145.
EK, B., WESTERMARK, B., WASTESON, A. & HELDIN, C.-H. (1982).
Stimulation of tyrosine-specific phosphorylation by platelet-
derived growth factor. Nature, 295, 419.
FRACKELTON, JR., A.R., TREMBLE, P.M. & WILLIAMS, L.T. (1984).
Evidence for the platelet-derived growth factor-stimulated
tyrosine phosphorylation of the platelet-derived growth factor
receptor in vivo. Immunopurification using a monoclonal
antibody to phosphotyrosine. J. Biol., Chem., 259, 7909.
GARRETT, J.S., COUGHLIN, R.S., NIMAN, H.L., TREMBLE, P.M.,
GILES, G.M. & WILLIAMS, L.T. (1984). Blockade of autocrine
stimulation in simian-sarcoma virus transformed cells reverses
down-regulation of platelet-derived growth factor receptors.
Proc. Natl Acad. Sci. USA, 81, 7466.
GOUSTIN, A.S., BETSHOLTZ, C., PFEIFER-OHLSSON, S. & 7 others
(1985). Co-expression of the sis and myc proto-oncogenes in
human placenta suggest autocrine control of the trophoblast
growth. Cell, 41, 301.
GREENBERG, M.W. & ZIFF, E.B. (1984). Stimulation of 3T3 cells
induces transcription of the c-fos proto-oncogene. Nature, 311,
433.
HAMMACHER A., HELLMAN, U., JOHNSSON, A. & 5 others (1988a).
A major part of PDGF purified from human platelets is a
heterodimer of one A and one B chain. J. Biol. Chem.
(submitted).
HAMMACHER, A., NISTtR, M., WESTERMARK, B. & HELDIN, C.-H.
(1986b). A human glioma cell line secretes three structurally and
functionally different dimeric forms of PDGF. Eur. J. Biochem.
(submitted).
HELDIN, C.-H. & RONNSTRAND, L. (1988). The platelet-derived
growth factor receptor. In Receptor Phosphorylation, Moudgil,
V.K. (ed), CRC Press (in press).
HELDIN, C.-H., WASTESON, A. & WESTERMARK, B. (1985). Platelet-
derived growth factor. Mol. Cell. Endocrinol., 39, 169.
HELDIN, C.-H., BETSHOLTZ, C., JOHNSSON, A. & WESTERMARK, B.
(1986a). Role of PDGF-like growth factors in malignant
transformation. Cancer Rev., 2, 34.
HELDIN, C.-H., JOHNSSON, A., WENNERGREN, S., WERNSTEDT, C.,
BETSHOLTZ, C. & WESTERMARK, B. (1986b). A human
osteosarcoma cell line secretes a growth factor structurally
related to a homodimer of PDGF A chains. Nature, 319, 511.
HUANG, J.S., HUANG, S.S. & DEUEL, T.F. (1984). Transforming
protein of simian sarcoma virus stimulates autocrine growth of
SSV-transformed cells through PDGF cell-surface receptors. Cell,
39, 79.
HUNTER, T. (1987). A thousand and one protein kinases. Cell., 50,
823.
JOHNSSON, A., HELDIN, C.-H., WESTERMARK, B. & WASTESON, A.
(1982). Platelet-derived growth factor: identification of
constituent polypeptide chains. Biochem. Biophys. Res. Comm.,
104, 66.
JOHNSSON, A., HELDIN, C.-H., WESTERMARK, B. & 9 others (1984).
The c-sis gene encodes a precursor of the B-chain of platelet-
derived growth factor. EMBO J., 3, 921.
JOHNSSON, A., BETSHOLTZ, C., HELDIN, C.-H. & WESTERMARK, B.
(1985). Antibodies against platelet-derived growth factor inhibit
acute transformation by simian sarcoma virus. Nature, 317, 438.
JOHNSSON, A., BETSHOLTZ, C., HELDIN, C.-H. & WESTERMARK, B.
(1986). The phenotypic characteristics of simian sarcoma virus-
transformed human fibroblasts suggest that the v-sis gene
product acts solely as a PDGF receptor agonist in cell
transformation. EMBO J., 5, 1535.
JOSEPHS, S.F., GUO, C., RATNER, L. & WONG-STAAL, F. (1984).
Human proto-oncogene nucleotide sequences corresponding to
the transforming region of simian sarcoma virus. Science, 223,
487.
KELLY, K., COCHRAN, B.H., STILES, C.D. & LEDER, P. (1983). Cell
specific regulation of the c-myc gene by lymphocyte mitogens
and platelet-derived growth factor. Cell, 35, 607.
KRUIJER, W., COOPER, J.A., HUNTER, T. & VERMA, I.M. (1984).
Platelet-derived growth factor induces rapid but transient
expression of the c-fos gene and protein. Nature, 312, 711.
LEAL, F., WILLIAMS, L.T., ROBBINS, K.C. & AARONSON, S.A.
(1985). Evidence that the v-sis gene product transforms by
interaction with the receptor for platelet-derived growth factor.
Science, 230, 327.
MARTINET, Y., BITTERMAN, P.B., MORNEX, J.-F., GROTENDORST,
G.R., MARTIN, G.R. & CRYSTAL, R.G. (1986). Activated human
monocytes express the c-sis proto-oncogene and release a
mediator showing PDGF-like activity. Nature, 319, 158.
MOOLENAAR, W.H., TERTOOLEN, L.G.J. & LAAT, S.W. (1984).
Growth factors immediately raise cytoplasmic free ca2+ in
human fibroblasts. J. Biol. Chem., 259, 8066.
MOLLER, R., BRAVO, R., BURCKHARDT, J. & CURRAN, T. (1984).
Induction of c-fos gene and protein by growth factors precedes
activation ofc-myc. Nature, 312, 716.
NILSSON, J., SJOLUND, M., PALMBERG, L., THYBERG, J. &
HELDIN, C.-H. (1985). Arterial smooth muscle cells in primary
culture produce a platelet-derived growth factor-like protein.
Proc. Natl Acad. Sci. USA. 82, 4418.
NISTER, M., HAMMACHER, A., MELLSTROM, K. & 4 others (1988a).
A glioma-derived PDGF A chain homodimer has different
functional activities than a PDGF AB heterodimer from human
platelets. Cell, 52, 791.
NISTER, M., LIBERMANN, T., BETSHOLTZ, C. & 5 others (1988b).
Possible autocrine loops involving PDGF/PDGF-receptor and
TGF-a/EGF-receptor pathways in human malignant glioma cell
lines. Cancer Res., (in press).
OWEN, A.J., PANTAZIS, P. & ANTONIADES, H.N. (1984). Simian
sarcoma virus-transformed cells secrete a mitogen identical to
platelet-derived growth factor. Science, 225, 54.
PAULSSON, Y., HAMMACHER, A., HELDIN, C.-H. & WESTERMARK,
B. (1987). Possible positive feed-back in the prereplicative phase
of human fibroblasts. Nature, 328, 715.
PEREZ, R., BETSHOLTZ, C., WESTERMARK, B. & HELDIN, C.-H.
(1987). Frequent expression of growth factors for mesenchymal
cells in human mammary carcinoma cell lines. Cancer Res., 47,
3425.
RAO, C.D., IGARASHI, H., CHIU, I.M., ROBBINS, K.C. &
AARONSON, S.A. (1986). Structure and sequence of the human
c-sis/platelet-derived growth factor 2 (SIS/PDGF 2) transcrip-
tional unit. Proc. Natl Acad. Sci. USA, 83, 2392.
ROBBINS, K.C., ANTONIADES, H.N., DEVARE, S.G., HUNKAPILLER,
M.W. & AARONSON, S.A. (1983). Structural and immunological
similarities between simian sarcoma virus gene product(s) and
human platelet-derived growth factor. Nature, 305, 605.
ROSS, R., RAINES, E.W. & BOWEN-POPE, D.F. (1986). The biology of
platelet-derived growth factor. Cell, 46, 155.
ROZENGURT, E., RODRIGUEZ-PENA, M. & SMITH, K.A. (1983).
Phorbol esters, phospholipase C and growth factors rapidly
stimulate the phosphorylation of a Mr 80,000 protein in intact
quiescent 3T3 cells. Proc. Natl Acad. Sci., USA, 80, 7244.
SEIFERT, R.A., SCHWARTZ, S.M. & BOWEN-POPE, D.F. (1984).
Developmentally regulated production of platelet-derived growth
factor-like molecules. Nature, 311, 669.
SEJERSEN, T., BETSHOLTZ, C., SJOLUND, M., HELDIN, C.-H.,
WESTERMARK, B. & THYBERG, J. (1986). Rat skeletal myoblasts
and arterial smooth muscle cells express the gene for the A chain
but not the B chain (c-sis) of platelet-derived growth factor
(PDGF) and produce a PDGF-like protein. Proc. Natl Acad. Sci.
USA, 83, 6844.
SHIMOKADO, K., RAINES, E.W., MADTES, D.K., BARRETT, T.B.,
BENDITT, E.P. & ROSS, R. (1985). A significant part of
macrophage-derived growth factor consists of at least two forms
of PDGF. Cell, 43, 277.
STROOBANT, P. & WATERFIELD, M.D. (1984). Purification and
properties of porcine platelet-derived growth factor. EMBO J., 3,
2963.
WATERFIELD, M.D., SCRACE, T., WHITTLE, N. & 7 others (1983).
Platelet-derived growth factor is structurally related to the
putative transforming protein p28sis of simian sarcoma virus.
Nature, 304, 35.
WESTERMARK, B., BETSHOLTZ, C., JOHNSSON, A. & HELDIN, C.-H.
(1986a). Acute transformation by simian sarcoma virus is
mediated by an externalized PDGF-like growth factor. In Viral
Carcinogens, Kjeldgard, N.O. & Forchhammaer, J. (eds), p. 445,
Munksgard: Copenhagen.
WESTERMARK, B., JOHNSSON, A., PAULSSON, Y. & 5 others
(1986b). Human melanoma cell lines of primary and metastatic
origin express the genes encoding the constituent chains of
PDGF and produce a PDGF-like growth factor. Proc. Natl
Acad. Sci. USA, 83, 7197.
YARDEN, Y., ESCOBEDO, J.A., KUANG, W.-J. & 10 others (1986).
Structure of the receptor for platelet-derived growth factor helps
define a family of closely related growth factor receptors. Nature,
323, 226.